DCF — FRANCISCAN HEALTH LAFAYETTE
Enterprise Value: $31.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$31.0M
Enterprise Value
$-0.7M
PV of Cash Flows
$31.6M
PV of Terminal Value
$50.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $389.0M | $12.4M | 3.0% | $-4.7M | $-4.3M |
| Year 2 | $400.7M | $16.8M | 4.0% | $-1.8M | $-1.5M |
| Year 3 | $412.7M | $21.4M | 5.0% | $1.2M | $0.9M |
| Year 4 | $425.1M | $24.2M | 6.0% | $2.8M | $1.9M |
| Year 5 | $437.8M | $26.0M | 6.0% | $3.7M | $2.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $31.0M. Terminal value accounts for 102% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$377.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.026957192938907883
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5